scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00259-016-3490-6 |
P698 | PubMed publication ID | 27557844 |
P50 | author | Konstantin Nikolaou | Q35704652 |
Stephan Kruck | Q46767633 | ||
Christian la Fougère | Q47460853 | ||
P2093 | author name string | Arnulf Stenzl | |
Christina Pfannenberg | |||
Gerald Reischl | |||
Johannes Schwenck | |||
Hansjoerg Rempp | |||
P2860 | cites work | Oligometastases. | Q55065168 |
In vivo visualization of prostate-specific membrane antigen in glioblastoma. | Q55460684 | ||
Oligometastases revisited | Q56773912 | ||
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy | Q56969116 | ||
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy | Q60606969 | ||
Processing of generator-produced 68Ga for medical application. | Q64947317 | ||
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases | Q77378855 | ||
Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis | Q81999680 | ||
Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis | Q85228088 | ||
[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice | Q85364606 | ||
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy | Q34683467 | ||
Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid | Q35008067 | ||
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | Q35043569 | ||
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer | Q37350456 | ||
Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer | Q37708013 | ||
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. | Q38049420 | ||
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis | Q38102842 | ||
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. | Q38983173 | ||
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging | Q39389586 | ||
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer | Q39636721 | ||
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells | Q40204286 | ||
Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitro | Q40312454 | ||
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy | Q40529844 | ||
Survival outcomes for oligometastasis in resected non-small cell lung cancer | Q40700961 | ||
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. | Q40959799 | ||
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases | Q42456087 | ||
Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET. | Q43613277 | ||
Physical and clinical performance of the mCT time-of-flight PET/CT scanner | Q43958296 | ||
More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer | Q44703542 | ||
Highly efficient automated synthesis of [(11)C]choline for multi dose utilization | Q44863225 | ||
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer | Q44994966 | ||
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis | Q46735738 | ||
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. | Q46877983 | ||
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. | Q46984864 | ||
Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods. | Q51000563 | ||
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. | Q52985406 | ||
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography. | Q52991043 | ||
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging. | Q53023502 | ||
Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial. | Q53068179 | ||
(68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. | Q53068468 | ||
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. | Q53131398 | ||
Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? | Q53272044 | ||
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. | Q53527477 | ||
P433 | issue | 1 | |
P921 | main subject | prostate cancer | Q181257 |
cancer metastasis | Q120912394 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 92-101 | |
P577 | publication date | 2016-08-24 | |
P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
P1476 | title | Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT | |
P478 | volume | 44 |